| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.22680 |
| P8608 | Fatcat ID | release_lgt2t47sx5c6dnos4572nhhgva |
| P698 | PubMed publication ID | 19177575 |
| P5875 | ResearchGate publication ID | 23957737 |
| P2093 | author name string | Thierry Gustot | |
| Christophe Moreno | |||
| Jacques Devière | |||
| Pieter Demetter | |||
| Raphaël Maréchal | |||
| Arnaud Lemmers | |||
| Delphine Degré | |||
| Eric Quertinmont | |||
| Vincent Vercruysse | |||
| Albert Geerts | |||
| Olivier Le Moine | |||
| Patricia de Nadai | |||
| P2860 | cites work | Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. | Q54715216 |
| Treatment of alcoholic liver disease | Q72847017 | ||
| Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls | Q73023725 | ||
| IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells | Q73163199 | ||
| Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines | Q73584928 | ||
| Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver | Q83182716 | ||
| Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells | Q24296669 | ||
| The biological functions of T helper 17 cell effector cytokines in inflammation | Q24614431 | ||
| A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage | Q28287540 | ||
| Interleukin-17 family members and inflammation | Q28287876 | ||
| ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding | Q28572528 | ||
| Steatohepatitis: a tale of two "hits"? | Q29547771 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Development, cytokine profile and function of human interleukin 17-producing helper T cells | Q29617131 | ||
| Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells | Q29618163 | ||
| IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 | ||
| Increased expression of interleukin 17 in inflammatory bowel disease | Q29622829 | ||
| Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. | Q33740453 | ||
| International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 | ||
| Cytokines in alcoholic and nonalcoholic steatohepatitis | Q34082594 | ||
| Epidemiology of alcoholic liver disease | Q34345871 | ||
| TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. | Q34579440 | ||
| Management strategies in alcoholic liver disease | Q34597743 | ||
| Neutrophil-mediated tissue injury in alcoholic hepatitis | Q34683345 | ||
| Monocyte activation in alcoholic liver disease | Q34683412 | ||
| Recent insights into the role of the innate immune system in the development of alcoholic liver disease. | Q35216526 | ||
| Review article: current management of alcoholic liver disease | Q35714125 | ||
| Immunologic mechanisms of alcoholic liver injury | Q35878863 | ||
| Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. | Q35962828 | ||
| Corticosteroids for alcoholic hepatitis--what's next? | Q36199267 | ||
| Th17: an effector CD4 T cell lineage with regulatory T cell ties | Q36510274 | ||
| Interleukin-17 as an effector molecule of innate and acquired immunity against infections | Q37038277 | ||
| Novel insights into the biology and physiology of the Ito cell | Q40478025 | ||
| Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies | Q40911465 | ||
| Increased tumor necrosis factor production by monocytes in alcoholic hepatitis | Q42505321 | ||
| T-cell activation, expression of adhesion molecules and response to ethanol in alcoholic cirrhosis. | Q42523104 | ||
| IL-17 enhances chemokine gene expression through mRNA stabilization | Q42824985 | ||
| IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts | Q43997188 | ||
| Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells | Q44009221 | ||
| Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells | Q44295997 | ||
| Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial | Q44673583 | ||
| Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. | Q45336150 | ||
| Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappaB in osteoblast-like cells | Q47587668 | ||
| Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. | Q50707448 | ||
| IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. | Q51687384 | ||
| Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. | Q53536111 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 646-657 | |
| P577 | publication date | 2009-02-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | The interleukin-17 pathway is involved in human alcoholic liver disease | |
| P478 | volume | 49 |
| Q85642040 | A Novel prognostic scoring system to predict 3-month mortality risk in patients with acute-on-chronic liver failure in hepatitis B: a retrospective cohort study |
| Q54987441 | A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It. |
| Q33871750 | Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. |
| Q37958079 | Acute-on-chronic liver failure in chronic hepatitis B. |
| Q86169994 | Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis |
| Q33742449 | Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development |
| Q92145075 | Alcohol-induced IL-17A production in Paneth cells amplifies endoplasmic reticulum stress, apoptosis, and inflammasome-IL-18 activation in the proximal small intestine in mice |
| Q37913987 | Alcoholic liver disease: pathogenesis and new targets for therapy |
| Q27690220 | Alcoholic liver disease: pathogenesis and new therapeutic targets |
| Q26861620 | Alcoholic liver disease: pathogenesis, management, and novel targets for therapy |
| Q37635136 | Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences |
| Q50724315 | Altered Distribution of Peripheral Blood Maturation-Associated B-Cell Subsets in Chronic Alcoholism |
| Q46450900 | Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models |
| Q37706081 | Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes. |
| Q37422630 | Anti-IL-17 antibody improves hepatic steatosis by suppressing interleukin-17-related fatty acid synthesis and metabolism |
| Q38254156 | Autophagy: a multifaceted partner in liver fibrosis |
| Q28553587 | Baicalin Attenuates IL-17-Mediated Acetaminophen-Induced Liver Injury in a Mouse Model |
| Q53092402 | Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice. |
| Q89685920 | Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice |
| Q41853274 | Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17. |
| Q43239293 | C57BL/6 and A/J Mice Have Different Inflammatory Response and Liver Lipid Profile in Experimental Alcoholic Liver Disease |
| Q37714863 | CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver |
| Q50867754 | Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver. |
| Q38311151 | Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology |
| Q27021577 | Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis |
| Q34795394 | Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. |
| Q34408850 | Chronic liver inflammation: clinical implications beyond alcoholic liver disease |
| Q42988617 | Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis? |
| Q36846983 | Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma |
| Q45355555 | Contribution of IL-17 to mouse hepatitis virus strain 3-induced acute liver failure |
| Q37625814 | Current understanding of osteoporosis associated with liver disease |
| Q33747793 | Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment |
| Q44371037 | Decreased peripheral blood CD4+/CD25+ regulatory T cells in patients with alcoholic hepatitis |
| Q36179395 | Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice |
| Q57143835 | Depletion of Foxp3+ Regulatory T Cells Promotes Profibrogenic Milieu of Cholestasis-Induced Liver Injury |
| Q42051159 | Deregulation of Regulatory T Cells in Acute-on-Chronic Liver Failure: A Rat Model |
| Q39039913 | Diethylcarbamazine: possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice |
| Q57463916 | Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis |
| Q34061724 | Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice |
| Q33579420 | Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. |
| Q35570778 | Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. |
| Q37246071 | Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study |
| Q87611687 | Effects of IL-17 on expression of GRO-α and IL-8 in fibroblasts from nasal polyps |
| Q37196725 | Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival |
| Q40130418 | Elevated levels of IL-22- and IL-17A-producing T helper cells in cholangiocarcinomarelated to liver fluke infection |
| Q30234425 | Emerging concepts in alcoholic hepatitis |
| Q37356353 | Epidemiology and treatment of autoimmune hepatitis |
| Q38927945 | Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation |
| Q33755829 | Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation |
| Q92492117 | Ex Vivo T Cell Cytokine Expression Predicts Survival in Patients with Severe Alcoholic Hepatitis |
| Q102389095 | Fibrosis: from mechanisms to medicines |
| Q42977019 | Finding a role for Th17 cells in hepatitis C pathogenesis |
| Q33550592 | Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes |
| Q30435033 | HCV+ Hepatocytes Induce Human Regulatory CD4+ T Cells through the Production of TGF-β |
| Q36076886 | HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients |
| Q84723541 | Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates |
| Q30414014 | Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes |
| Q36753243 | High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma |
| Q39625511 | High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV. |
| Q34571578 | Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course. |
| Q90813140 | Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury |
| Q33842114 | Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. |
| Q27025620 | IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression |
| Q36034788 | IL-17 Expression in the Time Course of Acute Anti-Thy1 Glomerulonephritis |
| Q84749635 | IL-17 contributes to autoimmune hepatitis |
| Q34289189 | IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-β receptor on hepatic stellate cells in a JNK-dependent manner |
| Q42925515 | IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis |
| Q42283750 | Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure |
| Q36269642 | Immune dysfunction in acute alcoholic hepatitis. |
| Q84654213 | Immune mechanisms in alcoholic liver disease |
| Q36104223 | Immunity and inflammatory signaling in alcoholic liver disease |
| Q38018539 | Immunological orchestration of liver fibrosis |
| Q102141646 | Immunopathobiology and therapeutic targets related to cytokines in liver diseases |
| Q43276074 | Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. |
| Q54288856 | Increased peripheral RORα and RORγt mRNA expression is associated with acute-on-chronic hepatitis B liver failure. |
| Q36895048 | Inflammation in alcoholic liver disease |
| Q35402168 | Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice |
| Q26778040 | Inflammatory status in human hepatic cirrhosis |
| Q26859951 | Innate immune cells in liver inflammation |
| Q37174755 | Innate immunity in alcoholic liver disease |
| Q38121575 | Interaction of hepatic stellate cells with diverse types of immune cells: foe or friend? |
| Q83066590 | Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection |
| Q47704613 | Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities |
| Q33883569 | Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression |
| Q85068847 | Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease |
| Q39333394 | Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice |
| Q43258398 | Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. |
| Q47814298 | Interleukin-17-targeted treatment of alcoholic liver disease |
| Q38645528 | Interleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinoma |
| Q35045751 | Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines |
| Q34163926 | Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3 |
| Q39882732 | Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. |
| Q41117896 | Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica |
| Q41831049 | Lentiviral vector-mediated down-regulation of IL-17A receptor in hepatic stellate cells results in decreased secretion of IL-6 |
| Q37747652 | Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis |
| Q56348332 | Liver and intestinal protective effects of Castanea sativa Mill. bark extract in high-fat diet rats |
| Q39065620 | Liver inflammation and fibrosis |
| Q48179127 | Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. |
| Q48246003 | Mesenchymal stem cells attenuate liver fibrosis by suppressing Th17 cells - an experimental study |
| Q101133373 | Molecular and cellular mechanisms of liver fibrosis and its regression |
| Q27692609 | Molecular mechanism and treatment of viral hepatitis-related liver fibrosis |
| Q33959178 | Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. |
| Q36351877 | Molecular targets in the treatment of alcoholic hepatitis |
| Q54969856 | Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. |
| Q37463756 | Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production |
| Q52603306 | NKT cells in liver diseases. |
| Q46142019 | NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL- 17 and TNF. |
| Q40410801 | Neutralization of Interleukin-17 Attenuates Cholestatic Liver Fibrosis in Mice. |
| Q36288405 | New Approaches for Studying Alcoholic Liver Disease |
| Q33757267 | New therapeutic targets in alcoholic hepatitis |
| Q26751402 | New treatment options for alcoholic hepatitis |
| Q34791455 | Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. |
| Q26824690 | Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications |
| Q98613138 | Oxidative stress in alcohol-related liver disease |
| Q37011836 | Pathogenesis and Management of Alcoholic Liver Disease |
| Q34750539 | Pathogenesis of alcoholic liver disease: role of oxidative metabolism |
| Q34998903 | Pathological role of interleukin-17 in poly I:C-induced hepatitis |
| Q26830338 | Pathology of Alcoholic Liver Disease |
| Q37696026 | Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. |
| Q37984817 | Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B. |
| Q36118056 | Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients. |
| Q36454261 | Preservation of hepatic blood flow by direct peritoneal resuscitation improves survival and prevents hepatic inflammation following hemorrhagic shock. |
| Q35673289 | Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences |
| Q34254438 | Protective Role of Interleukin-17 in Murine NKT Cell-Driven Acute Experimental Hepatitis |
| Q42211604 | Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells. |
| Q64897562 | Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease. |
| Q35928542 | Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis |
| Q90575102 | Regulatory T Cells Restrict Permeability to Bacterial Antigen Translocation and Preserve Short-Chain Fatty Acids in Experimental Cirrhosis |
| Q38738345 | Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment: A longitudinal observational study |
| Q35772972 | Retracted: Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation |
| Q27025680 | Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets |
| Q37825436 | Role of IL-17 and Th17 cells in liver diseases |
| Q38333417 | Role of adaptive immunity in alcoholic liver disease |
| Q26776506 | Role of microRNAs in Alcohol-Induced Multi-Organ Injury |
| Q45347964 | Should we try antiviral therapy for hepatitis C virus infection with pyoderma gangrenosum-like lesions? |
| Q90250634 | Specific Commensal Bacterium Critically Regulates Gut Microbiota Osteoimmunomodulatory Actions During Normal Postpubertal Skeletal Growth and Maturation |
| Q52574737 | Synergistic effect of interleukin-17 and tumor necrosis factor-α on inflammatory response in hepatocytes through interleukin-6 dependent and independent pathways. |
| Q92949036 | Systemic effects of IL-17 in inflammatory arthritis |
| Q27002418 | T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage |
| Q38162223 | T helper 17 cells in autoimmune liver diseases |
| Q90613619 | Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders |
| Q39392481 | Targeting inflammation for the treatment of alcoholic liver disease |
| Q37067749 | Th17 cells and their associated cytokines in liver diseases |
| Q43036898 | Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. |
| Q26773226 | The Role of Innate Immunity in Alcoholic Liver Disease |
| Q51761921 | The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis. |
| Q38175384 | The effect of inflammatory cytokines in alcoholic liver disease. |
| Q34367509 | The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation |
| Q39311652 | The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease |
| Q37778758 | The potential of cytokines as safety biomarkers for drug-induced liver injury |
| Q54343267 | The presence of Helicobacter pylori in the liver depends on the Th1, Th17 and Treg cytokine profile of the patient. |
| Q36922236 | The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis |
| Q36931974 | The role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver Disease |
| Q39450245 | The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review). |
| Q33906565 | The role of chemokines in the recruitment of lymphocytes to the liver |
| Q38658553 | The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update |
| Q83195671 | The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis |
| Q53712515 | Thymic NF-κB-inducing kinase regulates CD4+ T cell-elicited liver injury and fibrosis in mice. |
| Q39150702 | Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet |
| Q42695159 | Treatment options for alcoholic and non-alcoholic fatty liver disease: A review |
| Q64889194 | Two phase kinetics of the inflammatory response from hepatocyte-peripheral blood mononuclear cell interactions. |
Search more.